BridgeMD
New treatment option for Stimulant Use Disorder
Official title Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder
ClinicalTrials.gov ID: NCT06790576
What this study is testing
- What it's testing
- The study will recruit 50 adults with stimulant use disorder currently in treatment and abstinent for at least 2 weeks. The study will also recruit up to 10 healthy controls (adults without StUD) for initial study configuration.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Age 18 or older
- Ability to provide consent and comply with all study procedures.
- Meets Diagnostic and Statistical Manual of Mental Disorders criteria for StUD (As assessed by MINI and self-report; Participants may have current...
- At least 2 weeks of abstinence from substance use (other than caffeine or nicotine).
- Intention to remain in an addiction treatment program until intervention completion (does not apply to healthy control participants).
You likely can't join if
- Any organic brain disorder (e.g. TBI, stroke).
- Head injury resulting in skull fracture or loss of consciousness exceeding 30 minutes.
- TMS contraindication (history of seizures, metallic cranial plates/screws or implanted device).
- MRI contraindications (unapproved metallic implants, pacemakers or any other implanted electrical device, shrapnel, metallic braces, non-removable...
- Any psychotic disorder (Participants with other treated and stable psychiatric disorders will be included).
- Presence of a condition that would render study measures impossible to administer or interpret.
See the full eligibility criteria
- Age 18 or older
- Ability to provide consent and comply with all study procedures.
- Meets Diagnostic and Statistical Manual of Mental Disorders criteria for StUD (As assessed by MINI and self-report; Participants may have current comorbid drug use, but primary diagnosis must be StUD; does not apply to...
- At least 2 weeks of abstinence from substance use (other than caffeine or nicotine).
- Intention to remain in an addiction treatment program until intervention completion (does not apply to healthy control participants).
- Confident level of English language proficiency.
- Any organic brain disorder (e.g. TBI, stroke).
- Head injury resulting in skull fracture or loss of consciousness exceeding 30 minutes.
- TMS contraindication (history of seizures, metallic cranial plates/screws or implanted device).
- MRI contraindications (unapproved metallic implants, pacemakers or any other implanted electrical device, shrapnel, metallic braces, non-removable body piercings, pregnancy, breathing or movement disorder...
- Any psychotic disorder (Participants with other treated and stable psychiatric disorders will be included).
- Presence of a condition that would render study measures impossible to administer or interpret.
- Primary current substance use disorder diagnosis on a substance other than stimulants or cocaine, except for caffeine or nicotine.
- Greater than 9 months abstinence from substance use (does not apply to healthy control participants).
- Pregnancy or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.